Cite
HARVARD Citation
El Eit, R. et al. (2019). Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors. Cancer. 125 (16), pp. 2818-2828. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
El Eit, R. et al. (2019). Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors. Cancer. 125 (16), pp. 2818-2828. [Online].